Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

[1]  N. Xing,et al.  [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer]. , 2019, Zhonghua yi xue za zhi.

[2]  M. Carini,et al.  Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires , 2018, Urologia Internationalis.

[3]  M. Ogura,et al.  The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients. , 2017, Anticancer research.

[4]  Y. Chou,et al.  Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer? , 2015, Journal of the Chinese Medical Association : JCMA.

[5]  M. F. Fuentes Ferrer,et al.  Radical Cystectomy in Octogenarian Patients: A Difficult Decision to Take , 2015, Urologia Internationalis.

[6]  K. Nepple,et al.  Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care. , 2014, The Journal of urology.

[7]  M. Parmar,et al.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Saad,et al.  Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. , 2018, European urology.

[9]  J. Izawa,et al.  Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy , 2015, World Journal of Urology.

[10]  J. Portillo,et al.  Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO. , 1990, Progress in clinical and biological research.

[11]  G. Mead.  Bladder cancer. , 1990, Current opinion in oncology.